Resonance Specialties Ltd (RESONANCE) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Resonance Specialties Ltd on NSE and BSE, with an AI summary of each filing.
UNAUDITED FINANCIAL RESULTS FOR Q2 H1 FY2027
Financial Result · 30 Oct 2026, 5:33 pm
Resonance Specialties Reports Robust Q2 FY27 Results with Profit Surging YoY Resonance Specialties reported a strong performance for the quarter ended 30th Sep'26, with revenue from operations rising 59.2% YoY to ₹3,428.76 lakh (vs. ₹2,153.35 lakh in Q2 FY26) and up 5.2% QoQ. Net profit surged 411% YoY and 47.4% QoQ to ₹846.71 lakh, lifting basic EPS to ₹7.33 from ₹1.44 in Q2 FY26. For H1 FY27, revenue reached ₹6,687.17 lakh, driven by exports of ₹4,930.79 lakh, while net profit rose to ₹1,421.13 lakh. Total borrowings were fully repaid by 30th Sep'26.
OUTCOME OF BOARD MEETING HELD ON 30.10.2026
Outcome · 30 Oct 2026, 5:28 pm
Resonance Specialties Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 3,429 (+59.2% YoY | +5.2% QoQ) ■ EBITDA: 1,090 (+361.7% YoY | +46.1% QoQ) ■ EBITDA Margin (%): 31.8 (+2083 bps YoY | +890 bps QoQ) ■ PAT: 847 (+411.0% YoY | +47.4% QoQ) ■ EPS (INR): 7.33 (+409.0% YoY | +47.2% QoQ)
Resonance Specialties Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve to consider and approve ....
Intimation · 30 Oct 2026, 5:30 am
Resonance Specialties Schedules Board Meeting for Q2 FY27 Results Resonance Specialties Limited has scheduled its Board of Directors meeting for 30th Oct'26 to consider and approve the unaudited financial results for the second quarter and half year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company securities has been closed from the close of business hours on 30th Sep'26 and will remain shut until 48 hours after the declaration of the financial results.
Disclosure in terms of Regulation 30 of SEBI (LODR), 2015 regarding ratings assigned by CRISIL
Others (Uncategorized) · 26 Aug 2026, 9:00 pm
Resonance Specialties' Credit Ratings Reaffirmed by CRISIL In a disclosure dated Aug 26, '26, Resonance Specialties Limited announced that CRISIL has reaffirmed its credit ratings. The total bank loan facilities of Rs 14 Crore retained a 'CRISIL BBB-/Stable' rating. This includes Rs 2 Crore in proposed fund-based bank limits and a Rs 12 Crore working capital facility, both of which were also assigned a 'CRISIL BBB-/Stable' rating. The reaffirmation indicates a stable credit outlook for the company's financial instruments.
Voting Results of 37th AGM held on 04.08.2026 along with Scrutinizer''s Report.
Annual General Meeting · 05 Aug 2026, 9:14 pm
Proceedings of 37th AGM held on 04.08.2026
Annual General Meeting · 04 Aug 2026, 7:04 pm
PURCHASE OF MANUFACTURING UNIT FROM KAYGEE LABORATORIES PVT LTD
Others (Uncategorized) · 04 Aug 2026, 5:45 pm
Resonance Specialties to Acquire Related-Party Manufacturing Unit for ₹29.98 Crore Resonance Specialties Limited's board approved Q1'FY27 results and the purchase of a manufacturing facility from a related party, Kaygee Laboratories, for ₹29.98 crore on 04 Aug'26. The acquisition, subject to shareholder approval, will be a slump sale and is expected to complete by 30 Nov'26. The rationale is to secure its supply of chemical intermediates and APIs, enhance operational control, and reduce outsourcing costs. For Q1'FY27, net profit surged 252% YoY to ₹574.42 lakh, while revenue grew 53% YoY to ₹3,258.41 lakh.
UNAUDITED FINANCIAL RESULTS FOR Q1 FY27
Financial Result · 04 Aug 2026, 5:41 pm
Resonance Specialties to Acquire Related-Party Facility; Reports Strong Q1 Results Resonance Specialties' board approved Q1 FY27 results and the purchase of a manufacturing facility for ₹29.98 crores from a related party, Kaygee Laboratories Pvt Ltd. The deal aims to enhance operational control and secure production of key chemical intermediates and APIs. For the quarter ending 30 Jun'26, revenue from operations grew 53.2% YoY to ₹3,258.41 lakhs. Profit after tax surged 252.3% YoY to ₹574.42 lakhs, with basic EPS increasing to ₹4.98 from ₹1.41 a year ago. The transaction is subject to shareholder approval.
OUTCOME OF BOARD MEETING 04.08.2026
Outcome · 04 Aug 2026, 5:38 pm
Resonance Specialties to Acquire Related Party Unit; Reports Strong Q1 Results Resonance Specialties' board approved the purchase of a manufacturing unit from related party Kaygee Laboratories for ₹29.98 crores on a slump sale basis, expected to close by 30 Nov'26. The acquisition aims to secure production and enhance efficiency. For Q1FY27 (ended 30 Jun'26), the company reported a net profit of ₹574.42 lakhs, a 252% YoY increase. Revenue grew 53% YoY to ₹3,258.41 lakhs, driven by strong export growth. Basic EPS for the quarter stood at ₹4.98, up from ₹1.41 YoY.
Resonance Specialties Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the unaudited financial ....
Intimation · 04 Aug 2026, 5:30 am
Resonance Specialties Schedules Board Meeting for Q1 FY27 Results Resonance Specialties has scheduled a Board of Directors meeting on 04 Aug'26 to consider and approve the unaudited financial results for the first quarter ending 30 Jun'26. The trading window for insiders will remain closed from the close of business hours on 30 Jun'26 until 48 hours after the results are declared. This action is in compliance with SEBI's LODR regulations. The stock scrip code is 524218 on the BSE.
The Company has issued letters to those shareholders whose email address are not registered with the Company/Depository Participants/Registrar and Share Transfer Agent, providing the web ....
Annual Report · 11 Jul 2026, 8:53 pm
ANNUAL REPORT FOR FY 2025-26
Others (Uncategorized) · 09 Jul 2026, 4:16 pm
37th Annual General Meeting of the Company to be held on August 4, 2026.
Annual General Meeting · 07 Jul 2026, 11:55 pm
Intimation of Record Date 28/07/2026
Others · 07 Jul 2026, 11:35 pm
Resonance Specialties Announces Record Date for FY26 Dividend Resonance Specialties has set 28 Jul'26 as the record date to determine shareholder eligibility for a proposed dividend. The dividend is ₹1 per equity share, representing a 10% payout on the face value of ₹10 per share. This is subject to shareholder approval at the upcoming Annual General Meeting (AGM). If sanctioned, the dividend will be paid on or before 28 Aug'26. The announcement is for the Annual General Meeting and dividend entitlement.
RECOMMENDATION OF DIVIDEND FOR FY26 OF RE.1/- PER SHARE (10%)
Dividend · 14 May 2026, 6:22 pm
Resonance Specialties Reports Strong FY26 Results and Recommends Dividend Resonance Specialties posted a strong Q4 FY26, with revenue at ₹2,447.71 lakhs, up 1.1% YoY, and Net Profit rising 50.3% YoY to ₹459.56 lakhs. For the full year FY26, revenue grew 16.0% YoY to ₹9,024.75 lakhs, while Net Profit surged 58.3% to ₹1,039.58 lakhs. Basic EPS for FY26 stood at ₹9.01, up from ₹5.69 in FY25. The Board has recommended a dividend of ₹1/- per share (10%) for FY26, with the record date set for 28 Jul'26, subject to shareholder approval.
Re-appointment of M/s Kailash Chand Jain Co. Statutory Auditor for a period of 5years from the conclusion of 37th AGM till conclusion of 42nd AGM
Change in Auditor · 14 May 2026, 6:19 pm
Resonance Specialties Q4FY26 PAT Jumps 50% YoY; Recommends ₹1 Dividend Resonance Specialties posted strong Q4FY26 results with net profit at ₹459.56 lakh, up 50.3% YoY and 82.9% QoQ. Revenue from operations grew 1.1% YoY to ₹2,447.71 lakh. For FY26, net profit surged 58.3% YoY to ₹1,039.58 lakh on revenue of ₹9,024.75 lakh, a 16% YoY increase. The Board recommended a dividend of ₹1/share (10%) for FY26, with a record date of 28th Jul'26. Basic EPS for Q4 stood at ₹3.98, while FY26 EPS was ₹9.01. Additionally, M/s Kailash Chand Jain & Co. were re-appointed as auditors.
AUDITED RESULTS FOR FINANCIAL YEAR ENDED 31.03.2026
Financial Result · 14 May 2026, 6:16 pm
Resonance Specialties Limited - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakhs) ■ Revenue: 2448 (+1.1% YoY | +6.6% QoQ) ■ EBITDA: 564 (+33.2% YoY | +63.6% QoQ) ■ EBITDA Margin (%): 23.1 (+555 bps YoY | +803 bps QoQ) ■ PAT: 460 (+50.3% YoY | +82.9% QoQ) ■ EPS (INR): 3.98 (+51.3% YoY | +82.6% QoQ)
outcome of board meeting 14.05.2026
Outcome · 14 May 2026, 6:09 pm
Resonance Specialties Limited - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakhs) ■ Revenue: 2448 (+1.1% YoY | +6.6% QoQ) ■ EBITDA: 564 (+33.2% YoY | +63.6% QoQ) ■ EBITDA Margin (%): 23.1 (+555 bps YoY | +803 bps QoQ) ■ PAT: 460 (+50.3% YoY | +82.9% QoQ) ■ EPS (INR): 3.98 (+51.3% YoY | +82.6% QoQ)
Resonance Specialties Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve audited financial results ....
Intimation · 14 May 2026, 5:30 am
Resonance Specialties Schedules Board Meeting for Q4 Results and Dividend Recommendation Resonance Specialties Ltd will hold a Board of Directors meeting on 14th May'26 to consider and approve audited financial results for the fourth quarter and financial year ended 31st Mar'26. The board will also consider a dividend recommendation for the financial year. The trading window for insiders remains closed from 31st Mar'26 until 48 hours after the results are declared, a detail previously communicated on 16th Mar'25. The meeting's key outcomes will be the Q4FY26 financial performance and the proposed dividend payout.
Appointment of Mrs. Dhara Shah as an Independent Director of the Company.
Change in Management · 14 Mar 2026, 1:10 am
Resonance Specialties Appoints Dhara Shah as Independent Director via Postal Ballot Resonance Specialties Limited announced that shareholders have approved the appointment of Ms. Dhara Shah as an Independent Director for a five-year term. The resolution was passed via a postal ballot concluded on 13 Mar'26, with an overwhelming 99.996% of votes cast in favour. This special resolution received support from 35 members representing 6,271,950 votes, while 4 members with 229 votes were against. The appointment is a key governance update for the company.
Completion of tenure of Mrs. Archana Yadav (Din: 07335198) as an Independent Director of the Company.
Change in Management · 06 Feb 2026, 11:28 pm
Resonance Specialties: Independent Director Archana Yadav's Tenure Completes Resonance Specialties announced that Mrs. Archana Yadav (DIN: 07335198) will cease to be an Independent Director effective 8th Feb'26. This follows the completion of her second term, which concludes on 7th Feb'26. The change in board composition is a result of the natural end of her tenure as per regulatory requirements. No other details regarding her replacement or board changes were provided.
Appointment of Mrs. Dhara Shah as an Independent Director of the Company w.e.f 04.02.2026
Change in Management · 04 Feb 2026, 7:26 pm
Resonance Specialties Q3FY26 Results and Board Appointments Resonance Specialties reported Q3FY26 net profit of ₹251.28 lakhs, up 125.2% YoY and 51.6% QoQ. Revenue from operations grew to ₹2,296.27 lakhs, a 25.9% YoY increase. For the 9 months ended 31st Dec'25, net profit was ₹580.02 lakhs, up 65.3% YoY. The Board appointed Ms. Dhara Shah as an Additional/Independent Director for a 5-year term from 4th Feb'26. Mr. Raj Kamal Prasad Verma was appointed Chairman, replacing Mrs. Archana Yadav, whose term ends 7th Feb'26. The company also reconstituted its board committees.
UNAUDITED FINANCIAL RESULTS FOR Q3 AND 9 MONTHS ENDED DECEMBER 31, 2025.
Financial Result · 04 Feb 2026, 7:24 pm
Resonance Specialties Q3FY26 PAT Jumps 125%; Board Changes Announced Resonance Specialties reported a Q3FY26 Profit After Tax (PAT) of ₹251.28 lakhs, up 125.2% YoY and 51.6% QoQ. Revenue from operations grew 25.9% YoY to ₹2,296.27 lakhs. For 9M FY26, PAT stood at ₹580.02 lakhs (+65.3% YoY) on revenue of ₹6,577.04 lakhs (+22.7% YoY). The Board, on 4th Feb'26, appointed Ms. Dhara Shah as an Additional/Independent Director. Mr. Raj Kamal Prasad Verma was appointed Chairman, succeeding Mrs. Archana Yadav, whose term ends on 7th Feb'26.
UNAUDITED RESULTS FOR Q3 AND 9 MONTHS ENDED DECEMBER 31, 2025
Outcome · 04 Feb 2026, 7:18 pm
Resonance Specialties Limited - Financial Result for the Quarter ended 31st Dec'25 (Standalone, INR Lakhs) ■ Revenue: 2296 (+25.9% YoY | +6.6% QoQ) ■ EBITDA: 345 (+82.3% YoY | +46.1% QoQ) ■ EBITDA Margin (%): 15.0 (+465 bps YoY | +406 bps QoQ) ■ PAT: 251 (+125.3% YoY | +51.6% QoQ) ■ EPS (INR): 2.18 (+127.1% YoY | +51.4% QoQ)
Re-lodgement of transfer request of physical shares.
Others (Uncategorized) · 20 Jan 2026, 8:38 pm
Resonance Specialties Reports No Physical Share Transfer Requests for Dec'25 Resonance Specialties Limited informed the BSE on 20 Jan '26 that it received no requests for the re-lodgement of physical share transfers for the month ended 31 Dec '25. The company's Registrar and Share Transfer Agent, Adroit Corporate Services, confirmed that zero requests were received, processed, approved, or rejected during the period from 01 Dec '25 to 20 Jan '26, as per the SEBI circular dated 02 Jul '25. This indicates no activity related to physical share transfers under the special window.